Media center

The below is a joint press release between Amnesty International, the International Planned Parenthood Federation, MSI Reproductive Choices, the International Federation of Gynecology and Obstetrics (FIGO), International Confederation of Midwives and Ipas. People who are defending the right to abortion and providing essential services are being stigmatized, intimidated, attacked and subjected to unjust prosecutions, making their work increasingly difficult and dangerous to carry out, said Amnesty International in a new report out today. The report, An Unstoppable Movement: A global call to recognize and protect those who defend the right to safe abortions, reveals how many healthcare workers, activists, advocates and accompaniers around the world face abuse, arrest, prosecution and imprisonment for supporting the right of women, girls and people to access abortions. Such an environment is prevalent including in countries where abortion is partially allowed by law. It is having a chilling, silencing and stigmatizing effect on all those defending access to abortion, as they live in constant fear of being attacked and prosecuted for providing abortion care, whether it is legal or not. It is also creating major barriers for women, girls and people who need abortion care – particularly those who are most marginalised. “The right to abortion is not an opinion. It is a matter of international standards and international legal norms. It is a right underpinned by many human rights, including the rights to physical and mental integrity, the right to health and the right not to be unlawfully and arbitrarily killed through the withdrawal of safe services. It is essential for the dignity of all women and girls, and of everyone who can become pregnant. Those who defend and enable exercise of that right deserve our respect and protection. Yet, many States around the world persist with policies of over-regulation and criminalization that generate hostile, even perilous environments for those who defend the right to abortion,” said Agnès Callamard, Amnesty International’s Secretary General. “Anti-abortion rhetoric, policies and laws stamp a target on the backs of health workers and advocates. Stigmatized, abused, discriminated against, criminalized, imprisoned, even killed - the rights of those who defend the right to abortion are under attack. But their human rights to work without fear, to provide essential services without threat, to exercise their professional skills without discrimination, must be respected and protected.” Isolated and unsupported While progressive abortion law reform continues, anti-abortion regressions impede access with the promotion of disinformation and toxic narratives - smear campaigns that hijack public discourse and agitate against the right to abortion and against those who defend it. “For many sexual and reproductive health providers this harassment and abuse has come to feel like just part of the job, but we cannot allow this to become the new normal,” said Sarah Shaw, MSI Reproductive Choices’ Head of Advocacy. “Enough is enough. It’s time to recognise abortion providers as human rights defenders and stand up for those who put their lives on the line to make choice possible.” Throughout the report, based on more than 40 interviews with abortion rights defenders from all over the world and with the support of global healthcare and grassroots organizations, people defending the right to abortion, particularly healthcare workers, explained how they often feel isolated and unsupported. Their work is not recognised, and they are left fearing the threat of criminalization, harassment, stigmatization, verbal threats and violence, as well as ostracization and burnout in the workplace. Some health workers have seen their personal details leaked online, while others are unsure whether they’ll make it home safely. For example: Venezuelan teacher and human rights defender Vannesa Rosales was criminalized for helping a woman and her 13-year-old daughter get access to abortion. In Poland, Justyna Wydrzyńska, a member of Abortion Without Borders and the Abortion Dream Team, was convicted for helping a woman access abortion pills earlier this year - a safe way of terminating a pregnancy. In Ghana, an advocate for sexual and reproductive rights said service providers have experienced physical violence and public shaming by members of the public, for educating people about contraception. “Violence against frontline sexual and reproductive health care providers is something that continues to happen unabated; it's about time the voices, experiences and concerns of our frontline defenders are heard,” said Alvaro Bermejo, International Planned Parenthood Federation’s Director General. “As anti-abortion authorities around the world continue to deploy stigma, fear and hate-speech against those seeking and those providing services, we, as institutional champions of sexual and reproductive health and rights, commit to matching the courage of our frontline defenders.”

The recent approval of Japan's first oral abortion pill is an important step towards achieving gender equality and ensuring that women exercise their right to self-determination over their bodies, including pregnancy and childbirth. IPPF believes that true gender equality requires empowering women to be fully informed and in control of their bodies, thereby expanding their choices and enabling them to determine their own futures. Dr Alvaro Bermejo, Director General of the International Planned Parenthood Federation (IPPF), underlined the importance of this landmark milestone during a visit to Japan in April. Public support through public comments for the approval shows that the social situation in Japan is changing, with increased awareness of women's lives and health, reproductive freedom and women's rights. In its guidelines, the World Health Organisation (WHO) included oral abortion pills in the Essential Medicines Core List, in line with the evidence accumulated in the past, and removed the requirement of direct supervision by health professionals for their use as these pills can be used outside healthcare facilities without compromising safety and efficacy and the abortion process can be managed using the drug without direct supervision of health professionals. IPPF urges Japan to follow these WHO guidelines, including abortion as part of women's health care, and allow women to take safe oral abortion pills at home. Guaranteeing women in its own country access to these essential medicines is also in line with Japan's strong commitment and global pledge to achieve Universal Health Coverage (UHC), ensuring that all women have access to medicines that save their health and lives, and that no one is left behind. IPPF looks forward to, and is committed to working with and supporting, Japan's future steps towards achieving a society that supports true gender equality, where women can exercise their right to self-determination over reproduction.

Texas judge, Matthew Kacsmaryk, has suspended the U.S. Food and Drug Administration's (FDA) approval of the abortion pill Mifepristone in a horror move for abortion access across the United States. The decision will result in a nationwide ban on Mifepristone in seven days, with the FDA given one week to appeal the ruling. While the ban also affected access in states that have secured abortion post-Roe v Wade, a conflicting ruling from Judge Thomas O. Rice from a federal court in Washington state ordered the FDA to maintain access to Mifepristone in 17 democratic states and Colombia District – effectively putting access to the pill into limbo. Mifepristone, which has been FDA-approved for more than 22 years and has a safety record of over 99%[i], is taken alongside the drug Misoprostol during medical abortion procedures. Since then, it has been used by over 5 million[ii] Americans and was used in more than half of abortions nationwide last year. While Misoprostol can be used alone in medical abortion, people should have access to the full spectrum of abortion care options. Mifepristone is also used in the medical management of miscarriage and second and third-trimester pregnancies when the fetus has died before birth. While the ruling does not prohibit the FDA from making a new authorization for Mifepristone, this will likely take many months. Severe disruption to abortion care services, healthcare services and supply chain issues are expected as healthcare providers and pharmacies grapple with legality, stock, retraining and reeducation. Beth Schlachter, Director of Global Advocacy for the International Planned Parenthood Federation, said: "For 22 years, Mifepristone has been safely used in medical abortion care across the U.S., allowing healthcare providers to deliver safe, practical and discreet care to people who have chosen to end their pregnancies, regardless of their economic status or ability to travel. "In one fell swoop, anti-abortion extremists have once again stripped people of their rights in another blow to liberty. This horror ruling based on junk science, wilful distortion of fact and extreme political agendas will profoundly affect the lives of millions of people already struggling to access the care they need, especially in states where abortion is already banned." Anti-abortion extremists deliberately filed the case against the approval of Mifepristone in the Amarillo division of the Northern District of Texas — a single-judge division where cases are automatically assigned to Judge Matthew Kacsmaryk, a conservative judge appointed by former President Trump. The group claim that: "the statutory basis on which the FDA's approval of Mifepristone was issued 22 years ago is invalid" - an assertion both the Government Accountability Office and FDA have previously investigated and put to rest "an 1873 vice law that made it illegal to send "obscene, lewd or lascivious" material through the mail applies to abortion pills" - federal courts have consistently ruled it doesn't apply to lawful abortions "the drug's original approval wasn't supported by evidence of safety and efficacy" — a claim that medical and policy experts have continuously discredited Beth Schlachter, added: "The implementation of a national ban on Mifepristone via a state court debunks one of the principal anti-abortion arguments in the Roe v Wade case  - that the ruling curtailed state freedom and that abortion rights should be defined on a state-by-state basis. "This weaponization of federal courts by anti-abortion extremists proves just how dangerous the overturning of Roe v Wade is for everyday Americans, whose access to healthcare now lies in the hands of fanatical religious extremists determined to disrupt, harass and deceive until they end access to abortion care and long-held sexual and reproductive rights for good." The International Planned Parenthood Federation's local partner, the Planned Parenthood Federation of America, will continue to provide abortion care where safe and legal to do so. Those seeking medical abortion can also access care via AidAccess and WomenonWeb. At least two abortion networks, Trust Women and Whole Womans Health, have also announced that they will not immediately stop prescribing Mifepristone and will await a directive from the FDA – a move known as a conscientious provision which refers to providers who continue to provide care despite the legal parameters.   Alongside its partner and other reproductive health organizations, IPPF will keep fighting for access to abortion care, freedom from stigma and freedom from criminalization until everyone, everywhere, is free to make choices about their sexuality and well-being. [i] https://www.plannedparenthood.org/uploads/filer_public/42/8a/428ab2ad-3798-4e3d-8a9f-213203f0af65/191011-the-facts-on-mifepristone-d01.pdf [ii] Ibid For media enquiries, please contact Karmen Ivey at [email protected] or [email protected]   About the International Planned Parenthood Federation The International Planned Parenthood Federation (IPPF) is a global service provider and advocate of sexual and reproductive health and rights for all.  For 70 years, IPPF, through its 118 Member Associations and seven partners, has delivered high-quality sexual and reproductive healthcare and helped advance sexual rights, especially for people with intersectional and diverse needs that are currently unmet. Our Member Associations and partners are independent organizations that are locally owned, which means the support and care they provide is informed by local expertise and context. We advocate for a world where people have the information they need to make informed decisions about their sexual health and bodies. We stand up and fight for sexual and reproductive rights and against those who seek to deny people their human right to bodily autonomy and freedom. We deliver care that is rooted in rights, respect, and dignity - no matter what.  

Nairobi, Kenya: On 21st March 2023 the Ugandan parliament approved a law which, if enacted, would criminalise people for identifying as a member of the LGBTIQ+ community. The proposed law has been through two readings in parliament and is awaiting a third before it is put forward to the President for Assent. If passed, it will be a gross violation of and undermine the human rights and safety of people identifying as LGBTIQ+ in Uganda. IPPF Africa Region is strongly concerned about the numerous ways in which the passing of this law will violate international human rights including the right to life and dignity, freedom of expression and association, protection from discrimination, and will compromise the full and complete attainment of sexual and reproductive health and rights. Additionally, IPPF is extremely concerned about the dangerous message the law sends. In addition to criminalising consent, it encourages hatred, may escalate violence and gender-based violence targeting persons from LGBTIQ+ communities, popular justice, hinders the right to a fair trial, makes it easier to target minority groups, and harder for them to access justice and redress for hate crimes. At a time when countries around the world and in Africa are decriminalising same sex relationships, this law, if passed, will be a serious step backwards for Uganda. Marie-Evelyne Petrus-Barry, IPPF’s Africa Regional Director, said: "IPPF works to ensure the sexual and reproductive health and rights of all people regardless of their sexual orientation, gender identity and/or expression, and sex characteristics (SOGIESC) – including lesbian, gay, bisexual, trans, and intersex people – and ensure they have access to the full set of human rights enshrined in international human rights laws”  “IPPF is willing to work with the Ugandan Government and other stakeholders to ensure that all Ugandan people can access their sexual and reproductive rights without fear, discrimination, or restraint", added Petrus-Barry. IPPF strongly urges the President of Uganda to not sign off on this discriminatory law, uphold and safeguard the Universal Declaration and African Charter on Human Rights, and treat all Ugandans equally. IPPF stands with the LGBTIQ+ community in Uganda and globally at this difficult time. For further information or to request an interview, please contact: Mahmoud Garga, Lead Specialist - Strategic Communication, Media Relations and Digital Campaigning, IPPF Africa Regional Office (IPPFARO) – email: [email protected] / Tel: +254 704 626 920 ABOUT IPPF AFRICA REGION (IPPFAR) The International Planned Parenthood Federation Africa Region (IPPFAR) is one of the leading sexual and reproductive health (SRH) service delivery organization in Africa, and a leading sexual and reproductive health and rights (SRHR) advocacy voice in the region. Headquartered in Nairobi, Kenya, the overarching goal of IPPFAR is to increase access to SRHR services to the most vulnerable youth, men and women in sub-Saharan Africa. Supported by thousands of volunteers, IPPFAR tackles the continent’s growing SRHR challenges through a network of Member Associations (MAs) in 40 countries. We do this by developing our MAs into efficient entities with the capacity to deliver and sustain high quality, youth focused and gender sensitive services. We work with Governments, the African Union, Regional Economic Commissions, the Pan-African Parliament, United Nations bodies among others to expand political and financial commitments to sexual and reproductive health and rights in Africa. Learn more about us on our website. Follow us on Facebook, Twitter, Instagram and You Tube.  

Profamilia – an IPPF Member Association and the leading sexual and reproductive rights organization in Colombia – is celebrating the first anniversary of the decriminalization of abortion across the country. The move - Ruling C-055 - which allows abortion up to 24 weeks of gestation under any circumstance is saving lives across Colombia, and means those who have an abortion no longer face prosecution or criminalization. A historic step for the rights of women and pregnant people both in the country and across Latin America. Over the last year, Profamilia via its nationwide network of more than 50 clinics has helped guarantee sexual and reproductive health and rights, focusing on providing safe abortion care services in person as well as the provision of telemedicine for rural women.   For a country which sees 132,000 cases annually of complications from unsafe abortions and 70 women lose their lives each year – the shift in focus to abortion as a public health issue means healthcare providers can now focus on providing life-saving care and ending unsafe abortion. Alongside the ruling, the Ministry of Health, has also regulated abortion services throughout Colombia via Resolution 051, reiterating that abortion is an essential and urgent health service, which women, including migrant women, and pregnant people (transgender men, trans masculinities, non-binary people, among others) must be able to access without restriction and for free. Further rulings also embeds the provision of sexual and reproductive health information into Colombian health services. Marta Royo, the Executive Director of ProFamilia, said: "Profamilia's commitment will always be to provide comprehensive, humanized and safe services that allow free and informed decision making, and we reiterate this today” "After one year it is possible to see the progress the country has made in terms of reproductive autonomy and rights for women and pregnant people. However, we must move from text to action, and ensure that decriminalization means healthcare. Profamilia's commitment will always be to provide comprehensive, humanized and safe services that allow free and informed decision making." Eugenia López Uribe, Regional Director of IPPF for the Americas and The Caribbean.